Sutro Biopharma CEO and leadership

Mr. Newell has over 20 years of senior management experience in the biotechnology industry. He joined Sutro Biopharma as CEO in January 2009. Previously, he served as the President of Aerovance, Inc., a venture-backed company developing clinical assets for respiratory diseases. Mr. Newell also was Chief Business Officer and Senior Vice President at publicly-traded QLT, Inc. and served in several senior management positions at public-traded Axys Pharmaceuticals, Inc. For the 15 years prior to joining Axys, Mr. Newell practiced corporate law in the San Francisco Bay Area. He is presently a member of the Board at SutroVax Inc. Mr. Newell is also a Board member on BIO’s Emerging Companies Section and Health Section and Chairman of the Board and a member of the Executive Committee of the California Life Sciences Association.

Edward 'Ed' Albini is a CFO at SUTRO BIOPHARMA, INC. and is based in San Mateo, California. He has experience at Genentech and has worked as Director, Financial Planning & Analysis at Christof Wiesner; VP/CFO at Novacea; and Auditor at Peat Marwick Mitchell & Co. Edward attended Haas School of Business - UC Berkeley, University of California Berkeley, and Santa Clara University.

Linda Fitzpatrick is a Chief People & Communications Officer at SUTRO BIOPHARMA, INC. and is based in South San Francisco, California. She has experience at Genentech and has worked as Senior VP:Human Resources at SUTRO BIOPHARMA, INC.; Senior VP at ARCA biopharma Inc; and VP:Human Resources & Corp Comm at GILEAD SCIENCES INC. Linda works or has worked as Former Board Chair, Board Member at San Mateo Public Library; Senior Human Resources Advisor at SUTRO BIOPHARMA, INC.; and Former Board Chair, Board Member at A Home Within. She attended San Francisco State University.

Hallam has served as Sutro's CSO since December 2010. Prior to Sutro, Hallam was Executive Vice President of Research & Development at Palatin Technologies, Inc., and held several senior management positions in various pharmaceutical companies, including AstraZeneca PLC, SmithKline & French Laboratories, Ltd., Glaxo Group Research Ltd., Roche Research and Rhone-Poulenc Rorer.

Mr. Newell has over 20 years of senior management experience in the biotechnology industry. He joined Sutro Biopharma as CEO in January 2009. Previously, he served as the President of Aerovance, Inc., a venture-backed company developing clinical assets for respiratory diseases. Mr. Newell also was Chief Business Officer and Senior Vice President at publicly-traded QLT, Inc. and served in several senior management positions at public-traded Axys Pharmaceuticals, Inc. For the 15 years prior to joining Axys, Mr. Newell practiced corporate law in the San Francisco Bay Area. He is presently a member of the Board at SutroVax Inc. Mr. Newell is also a Board member on BIO’s Emerging Companies Section and Health Section and Chairman of the Board and a member of the Executive Committee of the California Life Sciences Association.